Table 4.
Dilution | Company | |
---|---|---|
Primary antibodies | ||
Skeletal Muscle Myosin (F59) |
For WB: 1/200 For IF: 1/200 |
Santa Cruz Biotechnology, Dallas, Texas, USA |
Myogenin (5FD) |
For WB: 1/200 For IF: 1/200 |
|
MyoD (G-1) | For WB: 1/200 | |
TNPO3 (ab71388) |
For WB: 1/1,000 For IF: 1/200 For IEM: 1/20 |
Abcam, Cambridge, UK |
SRSF1 (96) |
For WB: 1/250 For IF: 1/100 |
Thermo Fisher Scientific, Waltham, Massachusetts, USA |
Actin (I-19) | For WB:1/500 | Santa Cruz Biotechnology, Dallas, Texas, USA |
Secondary antibodies | ||
Goat Anti-Mouse IgG (H + L), DyLight 488 | For IF: 1/1,000 | Thermo Fisher Scientific, Waltham, Massachusetts, USA |
Goat Anti-Rabbit IgG (H + L), DyLight 650 | For IF: 1/250 | |
Amersham ECL Anti-mouse IgG HRP-conjugated | For WB: 1/1,000 | GE Healthcare, Chicago, Illinois, USA |
Amersham ECL Anti-rabbit IgG HRP-conjugated | For WB: 1/1,000 | |
Anti-goat IgG HRP-conjugated | For WB: 1/10,000 | Jackson ImmunoResearch, Cambridge, UK |
Goat anti-rabbit conjugated with 10 nm colloidal gold particles | For IEM 1/20 | BBInternational, Cardiff, UK |